Moderna, a $54 billion pharmaceutical maker, saw its shares surge 170% after a press release announcing a “pivotal” mRNA melanoma therapy, despite providing no detailed...
Former White House press secretary Karoline Leavitt’s exit has triggered a rapid search for a replacement, with former press chief Dana Perino analyzing potential...